03:19 , Nov 2, 2018 |  BC Innovations  |  Targets & Mechanisms

FDA’s pediatric target picks

FDA is looking ahead of industry in its guideline on targets for pediatric oncology, which includes more than 50 not yet in company pipelines in a list of over 220 the agency has its eye...
17:40 , Nov 15, 2016 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Prostate cancer Cell culture and mouse studies suggest inhibiting DDX3 in combination with radiation treatment could help treat prostate cancer. In DDX3-expressing human prostate cancer cell lines, shRNA targeting DDX3 or a DDX inhibitor...
07:00 , Aug 2, 2012 |  BC Innovations  |  Distillery Techniques

Technology: Markers

Approach Summary Licensing status Publication and contact information Markers Subtype-specific somatic mutations in medulloblastoma Identification of new subtype-specific somatic mutations in medulloblastoma could aid the development of new treatments for the disease. Whole-exome hybrid capture...
07:00 , Aug 21, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Infectious disease HIV/AIDS Ring-expanded nucleosides; DEAD box polypeptide 3 (DDX3) Studies in cell culture and in mice identified ring-expanded nucleoside analogs...